Suppr超能文献

胆汁酸诱导的肝脏分泌物粘蛋白抑制脂肪细胞分化。

The bile acid induced hepatokine orosomucoid suppresses adipocyte differentiation.

机构信息

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA.

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA; Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, 77030, USA.

出版信息

Biochem Biophys Res Commun. 2021 Jan 1;534:864-870. doi: 10.1016/j.bbrc.2020.10.086. Epub 2020 Nov 7.

Abstract

Bile acids have recently emerged as key metabolic hormones with beneficial impacts in multiple metabolic diseases. We previously discovered that hepatic bile acid overload distally modulates glucose and fatty acid metabolism in adipose tissues to exert anti-obesity effects. However, the detailed mechanisms that explain the salutary effects of serum bile acid elevation remain unclear. Here, proteomic profiling identified a new hepatokine, Orosomucoid (ORM) that governs liver-adipose tissue crosstalk. Hepatic ORMs were highly induced by both genetic and dietary bile acid overload. To address the direct metabolic effects of ORM, purified ORM proteins were administered during adipogenic differentiation of 3T3-L1 cells and mouse stromal vascular fibroblasts. ORM suppressed adipocyte differentiation and strongly inhibited gene expression of adipogenic transcription factors such as C/EBPβ, KLF5, C/EBPα, and PPARγ. Taken together, our data clearly suggest that bile acid-induced ORM secretion from the liver blocks adipocyte differentiation, potentially linked to anti-obesity effect of bile acids.

摘要

胆汁酸最近被认为是具有多种代谢疾病有益影响的关键代谢激素。我们之前发现,肝脏胆汁酸过载会在脂肪组织中远程调节葡萄糖和脂肪酸代谢,从而发挥抗肥胖作用。然而,解释血清胆汁酸升高的有益影响的详细机制仍不清楚。在这里,蛋白质组学分析鉴定了一种新的肝激素——乳白蛋白 (ORM),它控制着肝脏-脂肪组织的串扰。遗传和饮食性胆汁酸过载都会使肝脏 ORM 高度诱导。为了研究 ORM 的直接代谢作用,在 3T3-L1 细胞和小鼠基质血管成纤维细胞的脂肪生成分化过程中给予纯化的 ORM 蛋白。ORM 抑制脂肪细胞分化,并强烈抑制脂肪生成转录因子如 C/EBPβ、KLF5、C/EBPα 和 PPARγ 的基因表达。总之,我们的数据清楚地表明,肝脏分泌的胆汁酸诱导的 ORM 阻止脂肪细胞分化,这可能与胆汁酸的抗肥胖作用有关。

相似文献

1
The bile acid induced hepatokine orosomucoid suppresses adipocyte differentiation.
Biochem Biophys Res Commun. 2021 Jan 1;534:864-870. doi: 10.1016/j.bbrc.2020.10.086. Epub 2020 Nov 7.
2
The Hepatokine Orosomucoid 2 Mediates Beneficial Metabolic Effects of Bile Acids.
Diabetes. 2024 May 1;73(5):701-712. doi: 10.2337/db23-0520.
3
The hepatic orosomucoid/α1-acid glycoprotein gene cluster is regulated by the nuclear bile acid receptor FXR.
Endocrinology. 2013 Oct;154(10):3690-701. doi: 10.1210/en.2013-1263. Epub 2013 Jul 16.
6
Heshouwu (Polygonum multiflorum Thunb.) ethanol extract suppresses pre-adipocytes differentiation in 3T3-L1 cells and adiposity in obese mice.
Biomed Pharmacother. 2018 Oct;106:355-362. doi: 10.1016/j.biopha.2018.06.140. Epub 2018 Jul 11.
7
Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
Am J Physiol Endocrinol Metab. 2006 May;290(5):E916-24. doi: 10.1152/ajpendo.00410.2005. Epub 2005 Dec 20.
8
Glucose availability controls adipogenesis in mouse 3T3-L1 adipocytes via up-regulation of nicotinamide metabolism.
J Biol Chem. 2017 Nov 10;292(45):18556-18564. doi: 10.1074/jbc.M117.791970. Epub 2017 Sep 15.

引用本文的文献

1
Bile acid regulation of xenobiotic nuclear receptors on the expressions of orosomucoids in the liver.
Am J Physiol Endocrinol Metab. 2025 Jun 1;328(6):E940-E951. doi: 10.1152/ajpendo.00417.2024. Epub 2025 May 6.
4
Serum alpha-1 acid glycoprotein and gallstone risk in US adult women: a cross-sectional analysis of the NHANES.
Front Nutr. 2025 Feb 12;12:1527717. doi: 10.3389/fnut.2025.1527717. eCollection 2025.
5
More than carriers, orosomucoids are key metabolic modulators.
Trends Endocrinol Metab. 2025 Jun;36(6):507-510. doi: 10.1016/j.tem.2024.11.015. Epub 2024 Dec 18.
6
Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases.
Med Rev (2021). 2024 Jun 4;4(4):262-283. doi: 10.1515/mr-2024-0020. eCollection 2024 Aug.
7
The Hepatokine Orosomucoid 2 Mediates Beneficial Metabolic Effects of Bile Acids.
Diabetes. 2024 May 1;73(5):701-712. doi: 10.2337/db23-0520.
8
Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective.
Genes Dis. 2022 Feb 2;10(3):825-847. doi: 10.1016/j.gendis.2021.12.011. eCollection 2023 May.
10
Into the Labyrinth of the Lipocalin α1-Acid Glycoprotein.
Front Physiol. 2021 Jun 8;12:686251. doi: 10.3389/fphys.2021.686251. eCollection 2021.

本文引用的文献

1
Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity.
Nat Commun. 2020 Apr 24;11(1):2024. doi: 10.1038/s41467-020-15963-w.
3
The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis.
Mol Metab. 2019 Dec;30:184-191. doi: 10.1016/j.molmet.2019.09.014. Epub 2019 Oct 4.
4
Mechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue.
Physiol Rev. 2019 Oct 1;99(4):1701-1763. doi: 10.1152/physrev.00034.2018.
6
Liver - master and servant of serum proteome.
J Hepatol. 2018 Aug;69(2):512-524. doi: 10.1016/j.jhep.2018.04.018. Epub 2018 Apr 28.
7
Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance.
Nat Rev Endocrinol. 2017 Sep;13(9):509-520. doi: 10.1038/nrendo.2017.56. Epub 2017 Jun 9.
8
Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice.
Hepatology. 2017 Aug;66(2):498-509. doi: 10.1002/hep.29199. Epub 2017 Jun 26.
9
Transcriptional Regulation of Adipogenesis.
Compr Physiol. 2017 Mar 16;7(2):635-674. doi: 10.1002/cphy.c160022.
10
An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant Pathways.
Mol Cell Proteomics. 2017 Apr;16(4):581-593. doi: 10.1074/mcp.M116.061440. Epub 2017 Feb 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验